You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...
A new study suggests that a simple treatment algorithm could significantly reduce disparities in multiple sclerosis care ...
When certified dog trainer Nanette Lai had an MS flare, she figured out workarounds to allow her to still take care of her ...
At Sunday's Vanity Fair Oscar Party, Selma Blair's service dog shone brightest. The actress gushes over Scout and gives an ...
The medication, which will be rolled out to patients with relapsing-remitting MS, is thought to be the first in Europe to be ...
The list price of Mavenclad is around £2,050 per 10mg tablet, although, Merck is providing it to the NHS in England at a ...
The Scottish Medicines Consortium is reviewing cladribine for broader use in relapsing forms of the condition.
Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...
A simple treatment algorithm may help reduce treatment disparities for Hispanic and Black people with multiple sclerosis (MS), according to a preliminary study released March 3, 2025, that will be ...
which can result in a flare-up of symptoms for a period of time. Those with relapsing-remitting MS can experience trouble with their vision, extreme fatigue and numbness, according to Johns Hopkins.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback